m2m st. marks corp.

360 south van brunt street
englewood, new jersey 07631

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 16, 2014

NYS DOS ID#
4593268

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - M2M ST. MARKS CORP.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Marine Corps Plane Crash: The Victims
    By THE NEW YORK TIMES - Thursday Jul 13, 2017

    Family members and friends have begun identifying many of the 16 American service members who died on Monday when their plane crashed in rural Mississippi.

    Source: NYT > Home Page
  • Could the Rockaways Survive Another Sandy?
    By LUIS FERRÉ-SADURNÍ - Thursday Jul 13, 2017

    Residents are bracing for the worst, wondering whether measures taken so far are enough to keep devastation of the Queens community at bay.

    Source: NYT > Home Page
  • Tim Tebow helps St. Lucie Mets set attendance mark
    By Post Sports Desk - Saturday Aug 5, 2017

    Sandy Alderson recently said the “entertainment” factor was a big reason why the Mets signed Tim Tebow to a minor-league deal. And he was right: Tebow entertains and brings in the fans. The St. Lucie Mets announced Friday that they set a new single season home attendance record of 108,057. “Look, we signed him because...

    Source: New York Post: Sports
  • Insurance Giant Aetna Is Leaving Hartford for New York City
    By SARAH MASLIN NIR - Thursday Jun 29, 2017

    Aetna will move to new headquarters in Manhattan, drawn by New York’s emergence as a digital powerhouse, as well as financial incentives.

    Source: NYT > Home Page
  • FDA advisers review data on potential 1st US gene therapy
    By LINDA A. JOHNSON, AP Medical Writer - Wednesday Jul 12, 2017

    Cancer experts who advise government regulators are reviewing what could be the first gene therapy approved in the U.S.The Food and Drug Administration panel is holding a hearing Wednesday to discuss the treatment developed by the University of Pennsylvania and Novartis Corp. The drugmaker is seeking approval to use the one-time treatment for children and young adults with advanced leukemia.

    Source: SFGATE.com: Top News Stories
  • Novel leukemia treatment could be 1st US gene therapy
    By Associated Press - Thursday Jul 13, 2017

    A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of Pennsylvania and Novartis Corp. The FDA usually follows recommendations from its expert panels, but isn’t...

    Source: New York Post: News
m2m st marks corp englewood ny